Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000019

COO and SVP, R&D acquired 5,128 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · COO and SVP, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-01-16 Exercise or conversion : show line 1 in the form +5,128 $0.47 $2,410 16,734 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-01-16 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −5,128 $0.47 2020-01-19 5,128 0 D
Loading xslF345X03/wf-form4_157964528662973.xml…